)
)
)
Eicosis Human Health
EicOsis is developing inhibitors of soluble epoxide hydrolase (sEHI) as a unique validated approach to chronic inflammatory disease. Our lead sEHI, EC5026, has completed Phase 1 clinical development with a safety profile supporting once-daily doses.
Address
DavisCA
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)